Sandoval Elisabeth has filed 9 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 20000 shares of VYNE Therapeutics Inc. ($VYNE) on December 12, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 12, 2025 | VYNE Therapeutics Inc. | $VYNE | Little Elisabeth Sandoval | Not found | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 42,589,000 | 9999.99% | 0.05% |
| June 10, 2025 | PROCEPT BioRobotics Corp | $PRCT | Sandoval Elisabeth | Director | A | Stock Option (Right to Buy) | 2771 | $0.00 | 2,771.0000 | 54,818,700 | 9999.99% | 0.01% |
| June 10, 2025 | PROCEPT BioRobotics Corp | $PRCT | Sandoval Elisabeth | Director | A | Common Stock | 1538 | $0.00 | 12,561.0000 | 54,818,700 | 13.95% | 0.00% |
| Dec. 12, 2024 | VYNE Therapeutics Inc. | $VYNE | Sandoval Elisabeth | Not found | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 10,273,000 | 9999.99% | 0.19% |
| June 4, 2024 | PROCEPT BioRobotics Corp | $PRCT | Sandoval Elisabeth | Director | A | Common Stock | 1376 | $0.00 | 11,023.0000 | 0 | 14.26% | 0.00% |
| June 4, 2024 | PROCEPT BioRobotics Corp | $PRCT | Sandoval Elisabeth | Director | A | Stock Option (Right to Buy) | 2526 | $0.00 | 2,526.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2024 | VYNE Therapeutics Inc. | $VYNE | Sandoval Elisabeth | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 10,273,000 | 9999.99% | 0.19% |
| June 15, 2023 | PROCEPT BioRobotics Corp | $PRCT | Sandoval Elisabeth | Director | A | Common Stock | 2711 | $0.00 | 9,647.0000 | 0 | 39.09% | 0.00% |
| June 15, 2023 | PROCEPT BioRobotics Corp | $PRCT | Sandoval Elisabeth | Director | A | Stock Option (Right to Buy) | 4865 | $0.00 | 4,865.0000 | 0 | 9999.99% | 0.00% |